Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830933 · ClinicalTrials.gov registry record · NA
Breast Cancer Risk Reduction: A Patient Doctor Intervention
A NA study of Breast Cancer, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,235
- Enrollment target
- 2
- Study locations
NCT01830933 is a NA study of Breast Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 1,235 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01830933, a NA study of Breast Cancer, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,235 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.
Conditions Studied
Interventions
- OTHER BreastCARE
Study Locations (2)
California
- San Francisco General Hospital (SFGH) - San Francisco
- University of California, San Francisco Mt. Zion campus - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,235 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01830933
The ClinicalTrials.gov registry entry for NCT01830933 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,235 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (56% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which BreastCARE is the first listed.
NCT01830933 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01830933 about?
NCT01830933 is a clinical study titled "Breast Cancer Risk Reduction: A Patient Doctor Intervention". The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer ris...
What is the current status of trial NCT01830933?
This trial is currently completed. It is a NA study. The enrollment target is 1,235 participants. The study started on 2011-06. Estimated completion is 2012-12.
What conditions does trial NCT01830933 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01830933?
The interventions under investigation include: BreastCARE (OTHER).
Who is sponsoring clinical trial NCT01830933?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01830933 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.